RPRX
Royalty Pharma Plc
NASDAQ · Healthcare · Biotechnology · US
$60.27
−1.13%Forward multiples
Based on analyst estimates
- P/E forward
- 11.92x
- P/E 2026E
- 11.30x
- P/E 2027E
- 10.37x
- P/E 2028E
- 9.20x
- P/S forward
- 7.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.00x
- PEG TTM
- 0.23x
- Price / book
- 3.93x
- Price / sales
- 10.58x
- Price / cash flow
- 9.02x
Enterprise value
- Enterprise value
- $37.9B
- EV / sales
- 14.95x
- EV / EBITDA
- 22.10x
- EV / EBIT
- 23.98x
- Market cap
- $26.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026